Essaven

Essaven: direct action anticoagulant gel

Essaven is a medicine that is used to treat diseases associated with circulatory disorders. Essaven belongs to the group of direct-acting anticoagulants and is produced by several companies in Germany and France.

The drug Essaven is presented in the dosage form of a gel, which is used for external use. The gel contains two active ingredients - dihydroergocriptine and sodium heparin. Dihydroergocryptine is an alpha-adrenergic receptor agonist and has a membrane-stabilizing effect on blood vessel cells. Sodium heparin, in turn, prevents the formation of blood clots and improves microcirculation.

Essaven is widely used in the treatment of chronic venous insufficiency, thrombophlebitis, varicose veins and other diseases associated with circulatory disorders. The drug helps reduce swelling, pain and other symptoms associated with poor circulation.

The manufacturers of Essaven - the companies Nattermann GmbH and Rhone-Poulenc Rohrer - are large pharmaceutical manufacturers with many years of experience in the production of quality medicines.

Despite the positive properties of the drug, before using Essaven, you should consult your doctor and read the instructions for use. Like any other medicine, Essaven may cause side effects such as allergic reactions, skin rashes and other unwanted effects.

In general, Essaven is an effective medicine that helps cope with circulatory disorders and improve the condition of the veins. However, its use must be carried out under the supervision of a physician and in accordance with the instructions.